Examworks Group Stock Price, News & Analysis (NYSE:EXAM)

$35.06 -0.06 (-0.17 %)
(As of 02/25/2018 03:10 AM ET)
Previous Close$35.06
Today's Range$35.05 - $35.17
52-Week Range$21.98 - $37.26
Volume3.56 million shs
Average Volume660,679 shs
Market Capitalization$1.46 billion
P/E Ratio233.73
Dividend YieldN/A
BetaN/A

About Examworks Group (NYSE:EXAM)

Examworks Group logoExamWorks Group, Inc. is a provider of independent medical examinations (IMEs), peer reviews, bill reviews, Medicare compliance, case management and other related services (IME services or the IME industry). The Company conducts its business through four geographic segments, namely, the United States, Canada, the United Kingdom and Australia. The Company provides IME services through its medical panel of credentialed physicians and other medical providers. Its clients include property and casualty insurance carriers, law firms, third-party claim administrators and government agencies that use independent services to confirm the veracity of claims by sick or injured individuals and to facilitate care for workers' compensation, automotive, personal injury liability and disability insurance coverage. The Company also provides a range of services, including Medicare compliance services, bill review services and case management services.

Receive EXAM News and Ratings via Email

Sign-up to receive the latest news and ratings for EXAM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Ambulance & Emergency Services
Sub-IndustryHealth Care Services
SectorHealthcare
SymbolNYSE:EXAM
CUSIP30066A10
Phone+1-404-9522400

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio233.733333333333
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS$0.15
Net IncomeN/A
Net Margins1.44%
Return on Equity3.60%
Return on Assets1.21%

Miscellaneous

EmployeesN/A
Outstanding Shares41,240,000

Examworks Group (NYSE:EXAM) Frequently Asked Questions

What is Examworks Group's stock symbol?

Examworks Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "EXAM."

How were Examworks Group's earnings last quarter?

Examworks Group, Inc. (NYSE:EXAM) posted its quarterly earnings data on Tuesday, May, 10th. The business services provider reported $0.08 earnings per share for the quarter, hitting analysts' consensus estimates of $0.08. The business services provider had revenue of $226.50 million for the quarter, compared to analyst estimates of $217.47 million. Examworks Group had a return on equity of 3.60% and a net margin of 1.44%. The company's revenue was up 15.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.05 earnings per share. View Examworks Group's Earnings History.

Who are some of Examworks Group's key competitors?

How do I buy Examworks Group stock?

Shares of Examworks Group can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Examworks Group's stock price today?

One share of Examworks Group stock can currently be purchased for approximately $35.06.

How big of a company is Examworks Group?

Examworks Group has a market capitalization of $1.46 billion.

How can I contact Examworks Group?

Examworks Group's mailing address is 3280 Peachtree Rd NE Ste 2625, ATLANTA, GA 30305-2457, United States. The business services provider can be reached via phone at +1-404-9522400.


MarketBeat Community Rating for Examworks Group (EXAM)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  182 (Vote Outperform)
Underperform Votes:  101 (Vote Underperform)
Total Votes:  283
MarketBeat's community ratings are surveys of what our community members think about Examworks Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Examworks Group (NYSE:EXAM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Examworks Group (NYSE:EXAM) Consensus Price Target History

Price Target History for Examworks Group (NYSE:EXAM)

Examworks Group (NYSE:EXAM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/19/2016Needham & Company LLCReiterated RatingHoldN/AView Rating Details
6/2/2016William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 2/25/2016 forward)

Earnings

Examworks Group (NYSE:EXAM) Earnings History and Estimates Chart

Earnings by Quarter for Examworks Group (NYSE:EXAM)

Examworks Group (NYSE EXAM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2016Q1$0.08$0.08$217.47 million$226.50 millionViewN/AView Earnings Details
2/23/2016Q4$0.05$0.10$199.06 million$208.50 millionViewListenView Earnings Details
11/4/2015Q3$0.09$0.17$204.53 million$206.00 millionViewListenView Earnings Details
7/28/2015Q2($0.10)($0.19)$201.70 million$208.70 millionViewListenView Earnings Details
5/5/2015Q115$0.05$0.05$192.50 million$196.32 millionViewListenView Earnings Details
2/18/2015Q4 2014$0.09$194.67 million$202.06 millionViewN/AView Earnings Details
11/4/2014Q314$0.06$0.08$195.80 million$204.10 millionViewListenView Earnings Details
7/29/2014Q214$0.04$0.09$184.52 million$196.45 millionViewListenView Earnings Details
5/6/2014Q114($0.04)($0.01)$166.64 million$173.00 millionViewListenView Earnings Details
2/25/2014Q413($0.06)($0.04)$151.51 million$158.80 millionViewListenView Earnings Details
10/30/2013Q3 2013($0.08)($0.06)$151.60 million$152.35 millionViewN/AView Earnings Details
7/30/2013Q2 2013($0.10)($0.08)$151.60 million$156.10 millionViewListenView Earnings Details
5/8/2013Q1 2013($0.07)($0.10)$145.57 million$148.70 millionViewListenView Earnings Details
2/27/2013Q4 2012($0.16)($0.08)$135.77 million$139.64 millionViewListenView Earnings Details
11/5/2012Q312($0.18)($0.14)$127.09 million$130.10 millionViewN/AView Earnings Details
8/2/2012($0.11)($0.10)ViewN/AView Earnings Details
5/9/2012($0.11)($0.13)ViewN/AView Earnings Details
2/28/2012($0.10)($0.15)ViewN/AView Earnings Details
11/3/2011Q3 2011($0.06)($0.08)ViewN/AView Earnings Details
5/10/2011($0.04)($0.02)ViewN/AView Earnings Details
3/3/2011($0.03)($0.20)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Examworks Group (NYSE:EXAM) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Examworks Group (NYSE:EXAM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Examworks Group (NYSE EXAM) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Examworks Group (NYSE:EXAM)
Insider Trades by Quarter for Examworks Group (NYSE:EXAM)

Examworks Group (NYSE EXAM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/6/2016De Castro Jose Migue FernandezCFOSell9,798$34.80$340,970.4050,069View SEC Filing  
6/3/2016Crystal B PatmoreEVPSell2,030$34.80$70,644.0021,043View SEC Filing  
6/3/2016James K PriceCEOSell3,853$34.81$134,122.93544,216View SEC Filing  
6/3/2016Kevin J KozlowskiInsiderSell2,435$34.80$84,738.0030,362View SEC Filing  
6/3/2016Richard E PerlmanChairmanSell3,160$34.81$109,999.60441,684View SEC Filing  
6/3/2016Wesley CampbellPresidentSell3,247$34.80$112,995.6029,642View SEC Filing  
3/9/2016Crystal B PatmoreEVPSell8,507$28.47$242,194.2929,730View SEC Filing  
3/9/2016Kevin J KozlowskiInsiderSell5,106$28.47$145,367.8236,793View SEC Filing  
3/9/2016Wesley CampbellPresidentSell6,805$28.47$193,738.3538,214View SEC Filing  
12/9/2015J Thomas PresbyDirectorBuy4,000$26.90$107,600.0071,886View SEC Filing  
9/4/2015Richard E. PerlmanChairmanSell247,217$34.16$8,444,932.72432,304View SEC Filing  
9/2/2015Crystal B. PatmoreEVPSell85,084$34.87$2,966,879.0827,400View SEC Filing  
9/2/2015Kevin J. KozlowskiinsiderSell70,000$34.36$2,405,200.0032,883View SEC Filing  
9/1/2015Clare ArguedasEVPSell10,222$35.03$358,076.6621,746View SEC Filing  
9/1/2015Wesley CampbellPresidentSell71,010$35.02$2,486,770.2043,837View SEC Filing  
6/15/2015William A ShutzerDirectorSell16,464$40.18$661,523.52View SEC Filing  
6/4/2015J Thomas PresbyDirectorSell20,000$39.44$788,800.00View SEC Filing  
6/3/2015William A ShutzerDirectorSell3,100$40.00$124,000.00View SEC Filing  
6/1/2015William A ShutzerDirectorSell16,900$41.12$694,928.00View SEC Filing  
5/7/2015J Thomas PresbyDirectorSell25,000$41.56$1,039,000.00View SEC Filing  
3/9/2015Crystal B PatmoreEVPSell3,295$39.82$131,206.90View SEC Filing  
3/9/2015De Castro Jose Migue FernandezCFOSell4,948$39.81$196,979.88View SEC Filing  
3/9/2015Kevin J KozlowskiInsiderSell3,960$39.67$157,093.20View SEC Filing  
3/9/2015Wesley CampbellPresidentSell5,278$39.66$209,325.48View SEC Filing  
5/13/2014Crystal PatmoreEVPSell119,460$32.30$3,858,558.0020,496View SEC Filing  
5/13/2014De Castro Jose Migue FernandezCFOSell207,440$32.30$6,700,312.0043,247View SEC Filing  
5/13/2014James PriceCEOSell814,897$32.30$26,321,173.10471,235View SEC Filing  
5/13/2014Kevin KozlowskiInsiderSell126,686$32.30$4,091,957.8024,605View SEC Filing  
5/13/2014Richard PerlmanChairmanSell939,025$32.30$30,330,507.50647,827View SEC Filing  
5/13/2014Wesley CampbellPresidentSell121,086$32.30$3,911,077.8032,796View SEC Filing  
5/13/2014William ShutzerDirectorSell474,567$32.30$15,328,514.10365,613View SEC Filing  
8/2/2013Clare ArguedasEVPSell46,027$24.02$1,105,568.54View SEC Filing  
8/2/2013Kevin J KozlowskiInsiderSell60,000$23.69$1,421,400.00View SEC Filing  
8/2/2013Wesley CampbellPresidentSell65,000$23.87$1,551,550.00View SEC Filing  
6/3/2013De Castro Jose Migue FernandezCFOBuy2,500$18.85$47,125.00View SEC Filing  
6/3/2013James K PriceCEOBuy11,000$18.92$208,120.00View SEC Filing  
5/13/2013Wesley CampbellPresidentSell50,000$18.25$912,500.00View SEC Filing  
3/4/2013Richard E PerlmanChairmanBuy14,500$14.30$207,350.00View SEC Filing  
3/1/2013James K PriceCEOBuy14,500$13.97$202,565.00View SEC Filing  
11/14/2012De Castro Jose Migue FernandezCFOBuy5,000$11.48$57,400.00View SEC Filing  
11/14/2012James K PriceCEOBuy18,000$11.51$207,180.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Examworks Group (NYSE EXAM) News Headlines

Source:
DateHeadline
Critical Survey: Examworks Group (EXAM) versus Accretive Health (RCM)Critical Survey: Examworks Group (EXAM) versus Accretive Health (RCM)
www.americanbankingnews.com - November 29 at 7:30 AM
Analyzing Accretive Health (RCM) and Examworks Group (EXAM)Analyzing Accretive Health (RCM) and Examworks Group (EXAM)
www.americanbankingnews.com - November 26 at 11:20 AM
Comparing Examworks Group (EXAM) & Accretive Health (RCM)Comparing Examworks Group (EXAM) & Accretive Health (RCM)
www.americanbankingnews.com - November 23 at 1:28 PM
Accretive Health (RCM) versus Examworks Group (EXAM) Financial ReviewAccretive Health (RCM) versus Examworks Group (EXAM) Financial Review
www.americanbankingnews.com - November 19 at 11:54 AM
Reviewing Examworks Group (EXAM) & Accretive Health (RCM)Reviewing Examworks Group (EXAM) & Accretive Health (RCM)
www.americanbankingnews.com - November 17 at 5:06 PM
Contrasting Examworks Group (EXAM) and Accretive Health (RCM)Contrasting Examworks Group (EXAM) and Accretive Health (RCM)
www.americanbankingnews.com - November 15 at 11:52 PM
Examworks Group, Inc. Company ProfileExamworks Group, Inc. Company Profile
biz.yahoo.com - January 29 at 10:10 PM
EXAMWORKS GROUP, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting orEXAMWORKS GROUP, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or
biz.yahoo.com - July 27 at 9:59 AM
EXAMWORKS GROUP, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEXAMWORKS GROUP, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - July 26 at 12:25 PM
Deals of the Day: Opportunity in U.K., Lawyers in the Line of FireDeals of the Day: Opportunity in U.K., Lawyers in the Line of Fire
blogs.wsj.com - July 13 at 5:13 PM
EXAMWORKS GROUP, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-BalEXAMWORKS GROUP, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Bal
biz.yahoo.com - June 29 at 8:34 AM
ExamWorks Announces Conditional Redemption of All $500 Million 5.625% Senior Notes Due 2023ExamWorks Announces Conditional Redemption of All $500 Million 5.625% Senior Notes Due 2023
www.nasdaq.com - June 24 at 5:00 PM
ExamWorks Group, Inc. -- Moodys assigns B2 CFR and B1 credit facilities ratings to ExamWorks Group; outlook stableExamWorks Group, Inc. -- Moody's assigns B2 CFR and B1 credit facilities ratings to ExamWorks Group; outlook stable
www.moodys.com - June 8 at 4:49 PM
United Technologies (UTX) Otis Wins Cruise Ship ContractUnited Technologies' (UTX) Otis Wins Cruise Ship Contract
www.zacks.com - June 7 at 5:03 PM
EXAMWORKS GROUP, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEXAMWORKS GROUP, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - June 2 at 9:20 AM

SEC Filings

Examworks Group (NYSE:EXAM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Examworks Group (NYSE:EXAM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Examworks Group (NYSE EXAM) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.